key: cord-0311606-pr27hkbk authors: Chan, Jo-Anne; Loughland, Jessica R; de la Parte, Lauren; Okano, Satomi; Ssewanyana, Isaac; Nalubega, Mayimuna; Nankya, Felistas; Musinguzi, Kenneth; Rek, John; Arinaitwe, Emmanuel; Tipping, Peta; Bourke, Peter; Andrew, Dean; Dooley, Nicholas; SheelaNair, Arya; Wines, Bruce D; Hogarth, Mark; Beeson, James; Greenhouse, Bryan; Dorsey, Grant; Kamya, Moses; Hartel, Gunter; Minigo, Gabriela; Feeney, Margaret; Jagannathan, Prasanna; Boyle, Michelle J title: Age dependent changes in circulating Tfh cells influence the development of functional antibodies to malaria in children date: 2021-12-13 journal: bioRxiv DOI: 10.1101/2021.12.12.472299 sha: 8865aaa2246b004d7a6735eb53bfc6c5fa838112 doc_id: 311606 cord_uid: pr27hkbk T-follicular helper (Tfh) cells are key drivers of antibodies that protect from malaria. However, little is known regarding the host and parasite factors that influence Tfh and functional antibody development. Here, we use samples from a large cross-sectional study of children residing in an area of high malaria transmission in Uganda to characterize Tfh cells and functional antibodies to multiple parasites stages. We identify a dramatic re-distribution of the Tfh cell compartment with age that is independent of malaria exposure, with Th2-Tfh cells predominating in early childhood, while Th1-Tfh cell gradually increase to adult levels over the first decade of life. Functional antibody acquisition is age-dependent and hierarchical acquired based on parasite stage, with merozoite responses followed by sporozoite and gametocyte antibodies. Antibodies were boosted in children with current infection, and were higher in females. The children with the very highest antibody levels had increased Tfh cell activation and proliferation, consistent with a key role of Tfh cells in antibody development. Together, these data reveal a complex relationship between the circulating Tfh compartment, antibody development and protection from malaria. Plasmodium falciparum malaria remains a leading cause of morbidity and mortality in children, and malaria control programs have been further negatively impacted by the SARS-CoV-19 pandemic (Organisation", 2020) . No vaccine yet approaches the efficacy of naturally acquired immunity, which provides nearly complete protection against symptomatic disease in older children and adults living in highly endemic areas. In such settings, the response to infection evolves slowly with age from acute, high-density, symptomatic infections in young children, to infections that are mostly lower density and asymptomatic in older children and adults. Immune development independently increases with both cumulative exposure and host age (Rodriguez-Barraquer et al., 2016 . A better understanding of the mechanisms underpinning immunity and the factors that influence how immunity is acquired is needed to inform the development of improved vaccines and therapeutics that target the immune response. An important mediator of protective immunity are antibodies that target the parasite to limit replication and parasite burden. Antibody development is driven by CD4 T-follicular helper (Tfh) cells that play key roles in germinal centres to activate naïve B cells and induce memory and antibody-producing B cells (Crotty, 2019) Circulating Tfh cells that resemble germinal center Tfh have been identified from peripheral blood (Vella et al., 2019) , and can be subdivided into Th1-, Th2-and Th17like subsets based on CXCR3 and CCR6 chemokine expression (Locci et al., 2013; Morita et al., 2011) . Different Tfh subsets have been associated with antibody induction, depending on the infecting pathogen or vaccine, and context of exposure. During experimental human malaria in previously malaria-naive adults, all subsets of Tfh cells are activated (Chan et al., 2020) . However only activated Th2-Tfh cells, and not other Tfh subsets, were associated with the induction of anti-malarial antibodies (Chan et al., 2020) . We have recently shown that activation of Tfh cells during malaria is influenced by age, with adults having greater Tfh activation during infection, particularly within the Th2-Tfh cell subset (Oyong et al., 2021) . In contrast, in children with malaria, activation is restricted to Th1-Tfh cells (Obeng-Adjei et al., 2015; Oyong et al., 2021) . The impact of this age-dependent activation of Tfh cells on antibody development in malaria is unknown. While antibodies have been recognised as essential mediators of protection from human malaria for over 50 years (Cohen et al., 1961) , more recent studies have shown that the functional capacity of antibodies can be a better correlate of protective immunity than their quantity/titre . Antibodies mediate a variety of effector functions, including fixing complement proteins and interacting with Fcγ receptors (FcγR) to promote opsonic phagocytosis and antibody-dependent cellular cytotoxicity. The importance of these antibody effector mechanisms is established across all parasite life stages. For example, complement fixing antibodies targeting liver and blood stages have been associated with protection from malaria (Boyle et al., 2015; Kurtovic et al., 2018; Reiling et al., 2019) , and are a critical mediator of transmission-blocking immunity (Healer et al., 1997; Read et al., 1994; Williamson et al., 1995) . Opsonic phagocytosis and FcγR-dependent functions have also been associated with protection from liver and blood stage infection Hill et al., 2013; Kurtovic et al., 2020a; Osier et al., 2014) . Little is known regarding the relative kinetics of acquisition of specific functional antibodies across different stages of the parasite as immunity develops. Due to the central role of Tfh cells in antibody development, targeting Tfh to maximize the induction of functional antibodies may be key to achieving highly efficacious malaria vaccines Kurtovic et al., 2020b) . Thus, it is important to identify factors that influence Tfh cell development, particularly in children with high malaria exposure, and to determine how Tfh development and activation influence antibody acquisition. Here, we examined Tfh cells and functional antibodies against multiple parasites stages in Ugandan children ages 0-10 with high malaria exposure, and investigated the impact of age and malaria on immune development. Our findings reveal important host and malaria impacts on both Tfh cells and antibody responses that inform vaccine development. We analysed Tfh cells in children enrolled in a longitudinal observational cohort in Nagongera, eastern Uganda (Kamya et al., 2015) . For the present study, samples were collected between January and April 2013 during a period of high malaria burden, with an average entomological inoculation rate of 215 infectious bites per person per year (Kilama et al., 2014) . Tfh cells were quantified by flow cytometry in 212 children aged 0-11 years (54% male) (Supplementary Figure S1) . Consistent with the very high exposure in this cohort, 42% of children had asymptomatic P. falciparum infection at the time of sampling. Individual P. falciparum infection risk was assessed by household mosquito exposure (mosquito counts performed in individuals' homes, monthly), which correlates with infection in this cohort Kilama et al., 2014; Rodriguez-Barraquer et al., 2018) Tfh cells (CXCR5+PD1+) increased as a proportion of all CD4 T cells with age, ( Figure 1A) . The proportion of Tfh cells was not impacted by current asymptomatic parasitemia, household mosquito exposure, nor sex ( Figure 1B-D) . Unexpectedly, within the Tfh cell compartment, there was a dramatic redistribution of Tfh subsets with age, with an increase in Th1-Tfh and a decrease of Th2-Tfh cells between ages 0-7 years (Tfh subsets analysed based on CXCR3 and CCR6 expression. Th1-CXCR3+CCR6-, Th2 -CXCR3-CCR6-, Th17 -CXCR3-CCR6+, Figure 1E ). Current infection and sex had no impact on Tfh subset distribution (Figure 1F/H) . There was a suggestion that household mosquito exposure was associated with the proportion of Th17-Tfh cells, however this was not dose dependent (reduced Th17-Tfh in children with >40-80 compared to those with >80 household mosquitos/day (Dunn test FDR adjusted p = 0.04, Figure 1G ). FoxP3+ Tfh (TfReg cells), have important roles in regulating germinal centre Tfh cells (Clement et al., 2019) . However, how these responses related to FoxP3+ Tfh cells in the periphery is unclear, and here the proportion of FoxP3+ Tfh cells was not modified by age, current infection, household mosquito exposure but there was trend to higher FoxP3+ Tfh cells in males (Supplementary Figure S2) . To determine whether the change in Tfh subset distribution within our Ugandan cohort was driven by age or unaccounted for levels of malaria infection (which are colinear with age in high transmission settings) and/or overall infectious diseases burden, we assessed Tfh cells within healthy, malaria naïve children and adults from low infectious diseases burden community within Australia. Consistent with an age driven change in the distribution of Tfh subsets, there was a marked decrease in Th2-Tfh cells in children, which then stabilised into adulthood. Concurrently, Th1-Tfh cells increased in children, and then stabilised into adulthood ( Figure 1I ). Taken together, these data suggest that the Tfh subset distribution undergoes marked changes during childhood, independent of malaria infection. During activation, Tfh cells upregulate inducible co-stimulator (ICOS) and the intracellular proliferation marker Ki67, which are required for Tfh cell function and development (Akiba et al., 2005; Herati et al., 2017; Rasheed et al., 2006) . As such, we assessed the impacts of age and malaria on ICOS and Ki67 expression on Tfh cells. Both ICOS+ and Ki67+ expression on Tfh cells decreased with age ( Figure 2A Because of the interplay of age, current asymptomatic malaria infection and household mosquito exposure (Kilama et al., 2014) , we used linear regression models to determine associations between these factors and ICOS/Ki67 expression in each Tfh subset. Age was associated with declining ICOS expression on Th1, Th2 and Th17 Tfh cells ( Figure 2G , Supplementary Table S1). In contrast, Ki67 expression decreased with age on Th1-and Th17-, but not Th2-Tfh cells. Ki67 but not ICOS expression, was higher on both Th1-and Th2-Tfh cells in children with a current asymptomatic infection ( Figure 2G , Supplementary Table S1). Sex had no impact on ICOS or Ki67 on any Tfh subset (data not shown). Thus, extending the previous observation that Tfh activation and proliferation during symptomatic malaria is restricted to Th1-like Tfh cells (Obeng-Adjei et al., 2015; Oyong et al., 2021) , asymptomatic parasitemia is associated with increases in proliferation in both Th1-and Th2-Tfh cell subsets. To investigate the relationship between Tfh cell compartment changes and antibody development, we comprehensively characterised malaria antibody responses in the cohort described above and an additional 50 children concurrently enrolled in the same study (total n=262). We measured antibodies to immunodominant blood stage (MSP2, AMA1), sporozoite stage (CSP) and gametocyte stage (Pfs230) antigens and evaluated the levels of IgG1, IgG3, and IgM along with functional antibodies that fixed complement, bound Fcγ receptors FcγRIIa and FcγRIII, and had the capacity to mediate opsonic phagocytosis by THP-1 monocytes (OPA). We have recently shown that opsonic phagocytosis by THP-1 monocytes is largely mediated by FcγRI (Feng et al., 2021) . As expected, the prevalence and magnitude of both IgG and IgM antibodies increased with age ( Figure 3A /B). Antibodies were first acquired to blood stage antigens MSP2 and AMA1, followed by sporozoite stage CSP, and finally gametocyte stage Pfs230. The large majority of children were seropositive to MSP2 and AMA1. In contrast, the majority of children had little antibody responses to gametocyte antigen Pfs230, with <50% seroprevalence for all antibody types even in older children ( Figure 3A ). For the blood stage antigen MSP2, IgG1 was the predominant subclass in young children, but switched to predominantly IgG3 with increasing age, consistent with previous publications (Dodoo et al., 2008; Duah et al., 2010; Noland et al., 2015; Taylor et al., 1998; Tongren et al., 2006) . In contrast, IgG1 was the predominant subclass for PfAMA1 across all ages. For both blood stage antigens MSP2 and AMA1, opsonic phagocytosis antibodies were acquired first, followed by FcγRIII and then FcγRIIa-binding antibodies. C1q-fixing antibodies were less prevalent (25.8 and 33.3% seropositive for MSP2 and AMA1 respectively). Functional antibodies mediating OPA were also acquired first for CSP. However, antibodies targeting CSP were incapable of binding dimers of FcγRIIa or FcγRIII. There were very low levels of FcγRIIa and FcγRIII-binding, and no C1q-fixing antibodies targeting Pfs230. To investigate the relationship between antibody responses, we calculated the correlation between magnitudes of antibodies of each type to each antigen ( Figure 3C ). For MSP2, IgG3 levels were strongly correlated with C1q, FcRIIa and FcRIII, Previous studies have consistently shown that antibody responses are boosted during infection. Consistent with this, the majority of antibody responses to blood stage antigens MSP2 and AMA1 were higher in children with a current asymptomatic P. falciparum infection (MSP2 IgG3, FcRIII, OPA; AMA1 IgG1, IgG3, C1q, FcRIIa, FcRIII, OPA, Figure 4A ). There was also some boosting to non-blood stage antigens, with increased OPA antibodies to both CSP and Pfs230 during infection. IgM antibodies were not increased to any antigens in currently infected children, in contrast with previous findings by ourselves and others Walker et al., 2020) . Household mosquito exposure was not associated with antibody responses (Supplementary Figure S3) . Sex influenced multiple antibody responses, with higher IgG3 and C1q to MSP2 and AMA1, and FcRIIa to MSP2 in female children ( Figure 4B ). Magnitude of antibody responses of IgG1, IgG3, IgM and functional antibodies that mediated complement fixation (C1q) To investigate whether Tfh phenotypes are associated with malaria-specific antibody development, we performed an unbiased principal components analysis (PCA) incorporating all Tfh and antibody responses from all individuals with complete data (n=211). This analysis identified four clusters of individuals ( Figure 5A ) that differed with respect to age and infection, but not household mosquito exposure and sex ( Figure 5B-E) . Children in cluster 1 were significantly younger than other clusters, followed by cluster 2 children, however there was no difference between clusters 3 and 4 ( Figure 5B ). Current infection was also associated with cluster (Chi-square test p=0.05), however infection between clusters 3 and 4 was comparable ( Figure 5C ). ICOS and Ki67 expression (in total or Tfh subset) on clusters 1-3 was consistent with age driven changes, that was associated with increased Tfh cells within CD4 T cells, increased Th1-Tfh and decreased Th2-Tfh, and reduced ICOS and Ki67 (Figure F-G) . In comparing cluster 3 to cluster 4 (which had comparable age distribution of individuals), cluster 4 had significantly reduced proportions of Th17-Tfh cells, increased ICOS on total Tfh and all subsets, and increased Ki67 on Th2-Tfh cells. Individuals in cluster 4 also had the very highest levels of cytophilic and functional antibodies compared to other clusters, including cluster 3. Together, PCA and clustering analysis is consistent with a strong impact of age on both Tfh and antibodies. However, this analysis also identifies two distinct clusters of older children, with individuals in cluster 4 with the highest antibodies also having increased ICOS expression on Tfh cells, and Ki67+ Th2-Tfh cells compared to similarly aged children in cluster 3. This finding is consistent with an important role of Th2-Tfh cell proliferation and Tfh activation in malaria antibody development (Bowyer et al., 2018; Chan et al., 2020; Minassian et al., 2021) . Table S3) . As an alternative approach, we modelled associations between both Tfh subsets and antibodies and the risk of infection using Least Absolute Shrinkage and Selection Operator (LASSO) regression modelling. This model is suited to selecting important components from multicollinear data and indicated that MSP2 OPA and IgG3, and AMA1 IgG1 antibodies, the proportion Th1-17-Tfh cells and current asymptomatic infection were important predictors that are associated with incidence of any density infection ( Figure 6C ). We next assessed the association of Tfh subsets and antibodies with odds of symptomatic malaria when infected as a measure of protection from disease. Ki67 on total Tfh cells and Th2-and Th17-Tfh subsets (Ki67 % of Tfh, % of Th2-Tfh and %Th17-Tfh) were associated with increased odds of symptoms when infected after adjusting for age and current infection ( Figure 6D, Supplementary Table S4 Figure 6E , Supplementary Table S5 ). Using LASSO modelling, MSP2 IgG3, AMA1 IgM and CSP OPA antibodies, along with age and asymptomatic infection were selected as factors that best predicted and were associated with reduced incidence of symptoms given infection. In contrast, Ki67 expression on Th17-Tfh and Th2-Tfh cells, and the proportion of Th2-Tfh cells were associated with increased incidence of symptoms given infection ( Figure 6F ). Together, these data reveal a complex relationship between the circulating Tfh compartment, antibody development, and protection from malaria. Our findings suggest an important role of cytophilic antibodies to blood stage antigens in protection from symptomatic malaria. helper CD4 T cells . However, little is known regarding the factors that influence Tfh cell development in children living in malaria-endemic settings, or their impact on the relative kinetics of acquisition of functional antibodies against different malaria parasite stages. Here, we show that the Tfh cell compartment changes dramatically with age, with a marked decrease in Th2-Tfh cells in the first 10 years of life in both malaria-exposed and malaria-naïve children. In malaria-exposed children, Tfh cell activation and proliferation also increased with age and were further influenced by current P. falciparum. In addition, we demonstrate that antibody acquisition with age followed a hierarchical order, and that age-dependent changes in antibody subclasses and functions differed with parasite stage and antigen target. Clustering analyses revealed that children with the highest levels of cytophilic antibodies had increased activation of Tfh cells and proliferating Th2-Tfh cells compared to similarly aged children. Importantly, cytophilic and functional antibodies to blood and sporozoite stage parasite proteins were associated with protection from symptoms among those with P. falciparum infection. Together, these results have implications for our understanding of Tfh cell biology in humans and antibody mediated immunity from malaria. We found that in malaria exposed and naïve populations, the Tfh cell compartment undergoes marked changes with age, with a significant decline in Th2-Tfh and an increase in Th1-Tfh cells in children. To the best of our knowledge, this is the first report of this age dependent re-distribution of Tfh subsets in children. The mechanisms driving this dramatic age redistribution of Tfh subsets are unknown, but may be connected to the overall maturation of the immune response with age. Indeed, Th1 supporting cytokines and Th1 CD4 T cell responses to infection only reach levels of adult maturity around age 5-10 (Kollmann et al., 2012) . While the specific mechanisms that mediate Th2-Tfh compared to Th1-Tfh development are largely unknown (Kim et al., 2018) , this maturation of the immune system to support Th1 response may be important. How these changes to Tfh subsets impact immune development with age requires further investigation. Changes to Tfh subset distributions were not further impacted by current asymptomatic infection in our cohort. However Understanding the acquisition of antibodies that protect against symptomatic malaria is crucial to inform the development of efficacious vaccines. Our study, for the first time, measured the magnitude and function of antibodies against immunodominant antigens from different parasite life cycle stages (blood, sporozoites and gametocyte antigens). We found that antibodies in this cohort were first acquired to blood stage antigens such as MSP2 and AMA1, while antibodies to sporozoite CSP and gametocyte Pfs230 were acquired later. These findings are consistent with previous results in which we have shown functional antibodies that bind FcγRIIa and FcγRIII are significantly higher to merozoites compared to CSP antigen in Kenya populations (Feng et al., 2021) . Differences in antibody acquisition across parasite stages are likely driven by antigen burden. Blood stages have the highest parasite burden due to ongoing replication of the parasite within red blood cells, and both MSP2 and AMA1 are abundantly expressed on the surface of merozoites (Gilson et al., 2006) . In contrast, sporozoites are hidden from the immune system due to their gliding motility through hepatocytes. Similarly, gametocytes reside within red blood cells and emerge only within the mosquito midgut, thus reducing their capacity to stimulate an immune response. The extremely slow and infrequent acquisition of functional antibodies to sporozoite stages is consistent with the minimal levels of sterile protection against hepatocyte infection in naturally exposed populations (Tran et al., 2013) . Similarly, low levels of functional antibodies targeting gametocyte stages suggest that transmission blocking immunity is low in children, and that children could remain a large reservoir of transmission despite their gradual development of immune protection from disease (Andolina et al., 2021) . Alongside parasite stage, it is clear that the fine specificities at the subsets and functional levels are also influenced by specific characteristics of the antigen. Here, MSP2 IgG3 responses dominated and correlated with functional capacity of antibodies, in contrast to AMA1 where IgG1 antibodies are dominant. This finding is consistent with previous reports of IgG3 dominance to some but not all merozoite antigens and specific protein epitopes (Cavanagh et al., 2001; Duah et al., 2010; Richards et al., 2010) . While the mechanisms mediating IgG3 or IgG1 dominance to specific parasite proteins is unknown, the presences of specific T-cell epitopes that induce strong IL10 responses alongside IFNg has been implicated from experimental models (Tongren et al., 2005) . Consistent with an important role of IL10 in skewing antibodies to IgG3, there is an age associated switch from IgG1 to IgG3 dominance for MSP2 antibodies seen here and in other studies (Duah et al., 2010; Taylor et al., 1998; Tongren et al., 2006) , that coincides to the development of IL10/IFNg co-producing malaria specific T cells within these same Ugandan children In our study, multiple cytophilic and functional antibodies to blood and sporozoite stage antigens were associated with protection from symptomatic infection, consistent with previous studies (Boyle et al., 2015; Hill et al., 2016; Kurtovic et al., 2020b Kurtovic et al., , 2020a Osier et al., 2014; Reiling et al., 2019) . Sex was also associated with antibody levels, with increased antibodies in female children. While sex-based differences in malaria antibodies have been understudied, this finding is consistent with a recent study in a different cohort of Ugandan children aged 7-16 where female children/adolescents had higher MSP1 and MSP2 antibodies compared to males (Apio et al., 2020) . Indeed, in other infection and vaccination settings, females generally have greater antibody responses and global IgG levels and B cells (Fink and Klein, 2018; Klein and Flanagan, 2016) . A recent study showed that female children have faster rates of parasite clearance compared to males (Briggs et al., 2020) . Hence, sex-based differences in antibody responses may play an important role in protection from malaria. There were several important limitations to our findings. First, samples were obtained from Ugandan children at a single cross-sectional timepoint. Although this study represents one of the largest studies to date, future studies will need to perform repeated assessments within children over time to determine the impact of age and malaria exposure on both antibody responses and T cell maturation. Second, the analysis of circulating Tfh responses evaluated bulk, and not antigen-specific Tfh cell responses (Oyong et al., 2021) . Although we identified important associations between Tfh populations, age, antibody acquisition and protection, future studies are planned to assess the antigen-specific and functional capacity of Tfh cell response in this population. In conclusion, in a large cohort of children living in a highly malaria-endemic setting, we describe dramatic redistribution of the Tfh cell compartment from Th2-Tfh Ugandan children cohort: Samples were obtained from 262 children enrolled in a longitudinal study by the East African International Centres of Excellence in Malaria Research conducted in the high transmission areas of Uganda Jagannathan et al., 2017; Kamya et al., 2015) . This cohort consists of 100 households within the rural Nagongera sub-county in the Tororo district, where malaria transmission is holoendemic with seasonal peaks from October to January and April to July. In each randomly selected household, one adult caregiver (>20 years) and all children (eligibility of those aged 6 months to 10 years) were enrolled in the study.Upon enrollment all study participants were given an insecticide treated bed net and followed for all medical care at a dedicated study clinic. Children who presented with a fever (tympanic temperature >38.0 °C) or history of fever in the previous 24 hours had blood obtained by finger prick for a thick smear. If the thick smear was positive for Plasmodium parasites, the patient was diagnosed with malaria regardless of parasite density, and treated with artemether-lumefantrine. Routine assessments were performed in the study clinic every three months, including blood smears and dry blood spots to detect for parasite infection. Negative blood smears obtained at routine assessments were tested for the presence of submicroscopic malaria parasites using loop-mediated isothermal amplification (LAMP). Blood was drawn from each participant at a single cross-sectional timepoint between January and April 2013. Malaria naïve cohort: PBMCs were collected from a healthy malaria-naive cohort of children . Written informed consent was obtained from all adult study participants and parents or legal guardians of the children. Recombinant MSP2 FC27 was expressed in E. coli as previously described (Stanisic et al., 2009) . PfAMA1 , full-length PfCSP and Pfs230D1M were expressed in the mammalian HEK293 cell expression system as previously described. The level of antibodies to recombinant P. falciparum antigens and merozoites were measured by ELISA as previously described (Stanisic et al., 2009 The capacity of human antibodies to fix complement C1q was measured as previously described (Boyle et al., 2015; Reiling et al., 2019) . Briefly, antigen coating and blocking was performed as described above for standard ELISA. After incubation with human antibody samples, purified human C1q (10μg/ml; Millipore) was added as a source of complement for 30 min at room temperature, followed by a rabbit anti-C1q (1/2000; inhouse) detection antibody and finally, a goat anti-rabbit IgG HRP (1/2500; Millipore) for 1h at room temperature. The level of C1q-fixation was developed using TMB liquid substrate (Sigma-Aldrich), reactivity was stopped using 1M sulphuric acid and measured as optical density at 450nm. Measuring antibodies that have the capacity to cross-link Fc receptors was performed as previously described (Feng et al., 2021; Kurtovic et al., 2020a; Wines et al., 2016) . Briefly, antigen coating and blocking was performed as described above for standard ELISA. After incubation with human antibody samples, 50μL of biotinylated recombinant soluble dimers (0.2μg/ml of dimeric FcgRIIa, 0.1μg/ml of dimeric FcgRIII; expressed in-house using the HEK293 system) were added to the plates and incubated for 1h at at 37°C. Subsequently, a streptavidin HRP-conjugated antibody (1/10000; Thermo Fisher Scientific) was added for 1h at 37°C. Colour detection was developed using TMB liquid substrate and measured as optical density at 450nm. Measuring opsonic phagocytosis of antigen-coated beads was performed as previously described (Feng et al., 2021) . Briefly, antigen-coated beads (5x10 7 beads/ml) were incubated with serum samples for 1h at room temperature before washing and co-incubation with THP-1 monocytes for 20 min at 37°C. The proportion of THP-1 cells containing fluorescent-positive beads was acquired by flow cytometry (FACS Verse, BD Biosciences) and analysed using FlowJo software. Negative controls from non-exposed Melbourne residents were included in all assays. Ex vivo Tfh phenotype and activation was assessed by flow cytometry. PBMCs were thawed in 10% FBS/RPMI, and rested for 2 hours at 37 o C,5% CO2. In brief, 1M PBMCs were stained with surface antibodies to identify Tfh subsets, CD3, CD4, CXCR5 PD-1, Malaria-naïve PBMCs were stimulated at 1:3 (PBMC: iRBC) ratio for 5 days at 37 o C, 5% CO2. Cells were incubated in RPMI supplemented with 10% FBS. After 5 days, Tfh activation was assessed by flow cytometry. All statistical data analyses were performed using Prism 7 (GraphPad), STATA Ward.D method with R Hmisc package. To assess the association between Tfh cells and antibodies once controlling for age, lower limit of antibodies magnitudes were set at 0.001 and then log transformed before analysis in linear regression modelling. For clustering analysis of individuals, only those with complete Tfh and antibody data were included. All data was transformed into z-scores and then PCA performed in factoextra and FactoMineR. Kmeans cluster number chosen in 'useful' package and kmeans clusters identified with 'stats; package in R. To assess the odds of infection and disease in the year following with antibody and Tfh subsets, routine assessments with active case detection were performed in the study clinic every 3 months, including blood smears and dry blood spots to detect parasite infections. Negative blood smears obtained at routine assessments were tested for the presence of sub-microscopic malaria parasites using loop-mediated isothermal amplification (LAMP) (Hopkins et al., 2013) . At the time of routine assessments, children were classified into four categories as described previously Jagannathan et al., 2017) : (1) no evidence of parasite infection; (2) asymptomatic, submicroscopic (LAMP positive) infection; (3) asymptomatic, blood smear positive infection, or (4) symptomatic malaria defined as fever with a smear positive infection, with a window of 21 days prior to and 7 days following the routine visit to ensure capture of malaria episodes that were recently treated or infections that soon became symptomatic. To assess relationships between cross-sectional antibody responses and the prospective odds of infection measured at repeated, quarterly routine assessments, the odds of any infection (defined as either LAMP positive or blood smear positive with or without symptoms) were calculated using multilevel mixed-effects logistic regression, accounting for repeat measures within individuals and clustered on household to account for multiple children in each individual household. In multivariate analysis, odds ratios for infection risk were adjusted for age (linear), current asymptomatic infection and household mosquito exposure (categorical 0-8, >8-40, >40-80, >80 mosquitos/household/day). Household mosquito exposure was calculated as described previously . For each individual, household mosquito exposure was calculated based on the mean household-level female Anopheles mosquito counts obtained from CDC light traps placed overnight (once per month) within the household of all trial participants (Kilama et al., 2014) . Mean female Anopheles mosquito counts from the prospective 12 months were calculated used in analysis as a categorical variable (0-8, >8-40, >40-80, and >80 mosquitos/household/day), based on analyses of the relationship between household mosquito exposure and P. falciparum infection . Similarly, to assess the odds of symptoms given infection (defined as cases if clinical symptoms when an infection was detected either by LAMP or blood smear) and odds of sub-patent infection given any infection (defined as LAMP positive only if LAMP or blood smear positive with or without symptoms) were calculated using multilevel mixed-effects logistic regression, accounting for repeat measures within individuals and clustered on household to account for multiple children in each individual household. In multivariate analyses, odds ratios were adjusted for age (continuous) and current infection. LASSO Poisson regression modelling was used to select the most informative prognostic factors for 1) incidence of density infections and 2) incidence of symptoms when infected across the multiple visits during the study period. Variables assessed include age, gender, daily mosquito exposure rate (continuous in log and categorical 0-8,>8-40, >40-80, >80), and OD values from 27 antibodies: The optimum lambdas were selected using 5-fold cross validation that achieves the minimum Poisson deviance. Relative variable importance of selected variables was described using standardized coefficients. Only children with complete information were included in the analyses (complete case analyses, n=211). R statistical software version 4.0.2 with R package "glmnet" was used (Friedman et al., 2010) . The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal Differences in Anti Malarial Antibody Concentrations and Specificities between Male and Female Ugandan Children Challenges and strategies for developing efficacious and long-lasting malaria vaccines CXCR3+ T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria The Development of Plasmodium falciparum-Specific IL10 CD4 T Cells and Protection from Malaria in Children in an Area of High Malaria Transmission IgM in human immunity to Plasmodium falciparum malaria Differential Patterns of Human Immunoglobulin G Subclass Responses to Distinct Regions of a Single Protein, the Merozoite Surface Protein 1 of Plasmodium falciparum Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity Th2-like T Follicular Helper Cells Promote Functional Antibody Production during Plasmodium falciparum Infection Follicular regulatory T cells control humoral and allergic immunity by restraining early B cell responses Gamma-globulin and acquired immunity to human malaria T Follicular Helper Cell Biology: A Decade of Discovery and Diseases Differential Patterns of IgG Subclass Responses to Plasmodium falciparum Antigens in Relation to Malaria Protection and RTS,S Vaccination Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort Human Immunization With a Polymorphic Malaria Vaccine Candidate Induced Antibodies to Conserved Epitopes That Promote Functional Antibodies to Multiple Parasite Strains Mechanisms and targets of Fcγ-receptor mediated immunity to malaria sporozoites The evolution of greater humoral immunity in females than males: implications for vaccine efficacy Regularization Paths for Generalized Linear Models via Coordinate Descent Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of the human malaria parasite Plasmodium falciparum Antibodies to Plasmodium falciparum Antigens Predict a Higher Risk of Malaria But Protection From Symptoms Once Parasitemic Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230 Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells Opsonising Antibodies to P. falciparum Merozoites Associated with Immunity to Clinical Malaria Merozoite Antigens of Plasmodium falciparum Elicit Strain-Transcending Opsonizing Immunity Highly Sensitive Detection of Malaria Parasitemia in a Malaria-Endemic Setting: Performance of a New Loop-Mediated Isothermal Amplification Kit in a Remote Clinic in Uganda Plasmodium falciparumspecific IgM B cells dominate in children, expand with malaria, and produce functional IgM Vδ2+ T cell response to malaria correlates with protection from infection but is attenuated with repeated exposure Malaria transmission, infection, and disease at three sites with varied transmission intensity in Uganda: implications for malaria control Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda The Transcription Factor Ets1 Suppresses T Follicular Helper Type 2 Cell Differentiation to Halt the Onset of Systemic Lupus Erythematosus Sex differences in immune responses Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure Multi-functional antibodies are induced by the RTS,S malaria vaccine and associated with protection in a phase I/IIa trial Complement in malaria immunity and vaccines Human Circulating PD-1+CXCR3-CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and bloodstage antigens Circulating Th1-Cell-type Tfh Cells that Exhibit Impaired B Cell Help Are Preferentially Activated during Acute Malaria in Malaria-induced interferon-γ drives the expansion of Tbethi atypical memory B cells World malaria report 2020: 20 years of global progress and challenges Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria Adults with Plasmodium falciparum malaria have higher magnitude and quality of circulating T-follicular helper cells compared to children Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing Targets of complementfixing antibodies in protective immunity against malaria in children Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia Quantifying Heterogeneous Malaria Exposure and Clinical Protection in a Cohort of Ugandan Children Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure Severe Malaria Infections Impair Germinal Center Responses by Inhibiting T Follicular Helper Cell Differentiation T-follicular helper cells in malaria infection and roles in antibody induction Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness▿ † Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria Epitope-Specific Regulation of Immunoglobulin Class Switching in Mice Immunized with Malarial Merozoite Surface Proteins Age, and Duration of Antigen Exposure Independently Regulate Immunoglobulin G Subclass Switching in Malaria An Intensive Longitudinal Cohort Study of Malian Children and Adults Reveals No Evidence of Acquired Immunity to Plasmodium falciparum Infection T follicular helper cells in human efferent lymph retain lymphoid characteristics Acquisition and decay of IgM and IgG responses to merozoite antigens after Plasmodium falciparum malaria in Ghanaian children Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG We thank Australian Red Cross Blood Service for providing malaria naïve samples.We thank all staff of Infectious Disease Research Collaboration, Uganda. We thank all study volunteers and their guardians.